CHEBI:6375 - lansoprazole

ChEBI IDCHEBI:6375
ChEBI Namelansoprazole
Stars
Last Modified22 February 2017
DownloadsMolfile
FormulaC16H14F3N3O2S
Net Charge0
Average Mass369.368
Monoisotopic Mass369.07588
SMILESCc1c(OCC(F)(F)F)ccnc1CS(=O)c1nc2ccccc2n1
InChIInChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
InChIKeyMJIHNNLFOKEZEW-UHFFFAOYSA-N
Wikipedia
Roles Classification
Biological Roles:
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor  An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that inhibits H+/K+-exchanging ATPase, EC 3.6.3.10. Such compounds are also known as proton pump inhibitors.
antibacterial agent  A substance (or active part thereof) that kills or slows the growth of bacteria.
analgesic  An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
Applications:
gout suppressant  A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout.
hypoglycemic agent  A drug which lowers the blood glucose level.
antifibrotic agent  Any agent which acts to reduce fibrosis.
anti-ulcer drug  One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
analgesic  An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
ChEBI Ontology
Outgoing Relation(s)
lansoprazole (CHEBI:6375) has role analgesic (CHEBI:35480)
lansoprazole (CHEBI:6375) has role anti-ulcer drug (CHEBI:49201)
lansoprazole (CHEBI:6375) has role antibacterial agent (CHEBI:33282)
lansoprazole (CHEBI:6375) has role antifibrotic agent (CHEBI:233423)
lansoprazole (CHEBI:6375) has role antineoplastic agent (CHEBI:35610)
lansoprazole (CHEBI:6375) has role EC 3.6.3.10 (H+/K+-exchanging ATPase) inhibitor (CHEBI:49200)
lansoprazole (CHEBI:6375) has role gout suppressant (CHEBI:35845)
lansoprazole (CHEBI:6375) has role hypoglycemic agent (CHEBI:35526)
lansoprazole (CHEBI:6375) is a benzimidazoles (CHEBI:22715)
lansoprazole (CHEBI:6375) is a pyridines (CHEBI:26421)
lansoprazole (CHEBI:6375) is a sulfoxide (CHEBI:22063)
IUPAC Name 
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
INNs  Source
lansoprazolChemIDplus
lansoprazolumChemIDplus
Synonyms  Source
AG 1749DrugBank
AgoptonChEMBL
LansoprazoleChEMBL
LansoxChEMBL
LanzoprazoleChEMBL
LanzorChEMBL
Brand Names  Source
BamaliteDrugBank
Lansoprazole component of prevpacChEMBL
LanzolDrugBank
LanzopralDrugBank
LanzulChEBI
LimpidexDrugBank
Manual XrefsDatabases
1547DrugCentral
D00355KEGG DRUG
DB00448DrugBank
EP174726Patent
LansoprazoleWikipedia
LSM-5064LINCS
US4628098Patent
Registry NumbersSources
Beilstein:4333393Beilstein
CAS:103577-45-3ChemIDplus
Citations